JCO Precision Oncology Conversations

American Society of Clinical Oncology (ASCO)

English Health & Fitness Medicine

Apple Podcasts Website RSS

Episodes 10

Avg. Duration 8m

Activity Highly Active

Since Aug 2024

Latest Episode May 2026

Outreach Signals

Features Guests

Publishing Details

Schedule

Monthly

Format

Episodic

Consistency

57%

Hosting

rss.libsyn.com

Contact & Outreach

About This Podcast

JCO Precision Oncology Conversations podcasts features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they examine groundbreaking research in the world of precision oncology and learn how these advancements are redefining treatment protocols. The year's fellows summarize the top JCO Precision Oncology articles in the series, JCO PO Article Insights.

Social Media

Explore Statistics

English Podcasts Report Health & Fitness Report Medicine Report English Health & Fitness Report

Recent Episodes

JCO PO Article Insights: Dynamic Monitoring of Anti-EGFR Resistance in Metastatic Colorectal Cancer

May 27, 2026 9m

In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti–Epidermal Growth Factor Receptor–Based Therapy…

Phase II Study of Seribantumab in Tumors Harboring NRG1 Fusions

May 20, 2026 22m

JCO PO author Dr. Tejas Patil at University of Colorado Cancer Center shares insights into the JCO PO article, "CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody,…

JCO PO Article Insights: Circulating Cancer Genome Atlas Study 5-year Outcomes

Apr 29, 2026 7m

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes…

JCO PO Article Insights: Analytical Validation of Tumor-Informed ctDNA Assays for MRD

Mar 25, 2026 11m

In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular…

Oncotype DX Breast Recurrence Score® Results from Paired CNB & SE Specimens

Feb 25, 2026 7m

In this JCO Precision Oncology Article Insights episode, host Dr. Carolyn Lineen summaries the article, "Concordance of Oncotype DX Breast Recurrence Score Assay Results Between Paired Core Needle…

ctDNA in Metastatic Invasive Lobular Carcinoma

Feb 18, 2026 27m

JCO PO author Dr. Foldi at UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine shares insights into the JCO PO article, "Personalized Circulating Tumor DNA Testing for…

JCO PO Article Insights: Circulating Tumor DNA in Germ Cell Tumors

Jan 28, 2026 6m

In this JCO Precision Oncology Article Insights episode, host Dr. Jiasen He summaries the article, "Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular…

FGFR2b Prevalence in Advanced GC: FORTITUDE-101 Prescreening

Jan 21, 2026 19m

JCO PO author Dr. Wainberg at UCLA shares insights into the JCO PO article, "Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III…

Palbociclib in Tumors with CDKN2A Loss or Mutation

Jan 07, 2026 9m

In this JCO Precision Oncology Article Insights episode, host Dr. Harold Nathan Tan summarizes "Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results…

FGFR3 Alteration Status and Immunotherapy in Urothelial Cancer

Dec 17, 2025 18m

JCO PO author Dr. Shilpa Gupta at Cleveland Clinic Children's Hospital shares insights into her article, "Fibroblast Growth Factor Receptor 3 (FGFR3) Alteration Status and Outcomes on Immune…

JCO PO Article Insights: Genomic Risk Classifiers in Localized Prostate Cancer

Nov 26, 2025 4m

In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes "Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized" by Góes et al. published on…

DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas

Nov 19, 2025 26m

Authors Drs. Jessica Ross and Alissa Cooper share insights into their JCO PO article, "Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in…

Somatic Mutations of Colorectal Cancer by Birth Cohort

Oct 29, 2025 7m

In this episode of JCO PO Article Insights, host Dr. Jiasen He summarizes the article, "Somatic Mutation Profiles of Colorectal Cancer by Birth Cohort" by Gilad, et al published October 11, 2025. …

Areas of Uncertainty in Pancreatic Cancer Surveillance

Oct 11, 2025 16m

JCO PO author Dr. Bryson Katona at the University of Pennsylvania Perelman School of Medicine shares insights into his article, "Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey…

Lynch Syndrome Mortality in the Immunotherapy Era

Oct 11, 2025 26m

JCO PO author Dr. Asaf Maoz at Dana-Farber Cancer Institute shares insights into article, "Causes of Death Among Individuals with Lynch Syndrome in the Immunotherapy Era." Host Dr. Rafeh Naqash and…

JCO PO Article Insights: A Retrospective Analysis to Identify ICI-Sensitive Populations

Sep 30, 2025 7m

In this JCO Precision Oncology Article Insights episode, Dr. Jiasen He summarizes JCO PO article "Synthetic Lethal Co-Mutations in DNA Damage Response Pathways Predict Response to Immunotherapy in…

Genomic Profile of Small Cell Bladder, Lung and Urothelial Cancer

Sep 24, 2025 17m

JCO PO authors Dr. Abhishek Tripathi and Dr. Salvador Jaime-Casas at City of Hope Comprehensive Cancer Center share insights into their article, "Comparative Genomic Characterization of Small Cell…

JCO PO Article Insights: MUC16 Directed BiTE Therapy in Epithelioid Sarcoma

Aug 27, 2025 5m

In this JCO PO Article insights episode, Dr. Jiasen He summarized the JCO PO article "Mucin 16–Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and…

BRCA-Altered Uterine Sarcoma Treated with PARP Inhibitors

Aug 20, 2025 24m

JCO PO author Dr. Alison M. Schram at Memorial Sloan Kettering Cancer Center shares insights into her JCO PO article, "Retrospective Analysis of BRCA-Altered Uterine Sarcoma Treated With…

JCO PO Article Insights: Prognostic Gene Expression Signature and MYC Expression in Osteosarcoma

Jul 30, 2025 4m

In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes "Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma" by…

Frequently Asked Questions

How many episodes does JCO Precision Oncology Conversations have?

JCO Precision Oncology Conversations has published 10 episodes since August 2024, covering topics in Health & Fitness, Medicine.

Is JCO Precision Oncology Conversations still active?

JCO Precision Oncology Conversations is currently highly active with new episodes monthly. Average episode length is 8m.

How do I contact JCO Precision Oncology Conversations for sponsorship or guest appearances?

Sign up on Grep.FM to access contact details for JCO Precision Oncology Conversations, including email and social media links.